Company / Current Liabilities
Minerva Neurosciences, Inc. Current Liabilities History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$2.8M
FY2024
5-year range
$1.4M / $3.3M
FY2020-FY2024
Trend
-15.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 8 years, ranging from $1M in FY2022 to $7M in FY2017.
Based on SEC 10-K filings.
$3M in FY2024 with a 5-year CAGR of -15.6%.
Increased from $1M to $3M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +0.2%
- 5-Year CAGR
- -15.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -15.6%, indicating a declining trend.
- In FY2024, current liabilities decreased 15.1% year-over-year.
- Peak current liabilities was recorded in FY2017.
- Lowest current liabilities in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.8M | -15.1% |
| FY2023 | $3.3M | +142.5% |
| FY2022 | $1.4M | -51.1% |
| FY2021 | $2.8M | -10.8% |
| FY2020 | $3.2M | -52.3% |
| FY2019 | $6.6M | +83.7% |
| FY2018 | $3.6M | -47.2% |
| FY2017 | $6.8M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026